Apollomics Inc. SEC filings APLM

Apollomics Inc. has 183 filings in SEC EDGAR's recent list, going back to Sep 14, 2022. Its latest annual report, Form 20-F, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Aug 12, 2026. The company's fiscal year ends on December 31.

Apollomics Inc. SEC filings
Form Description Filed Period
4/A Filing Sep 24, 2026 Sep 14, 2026
4/A Filing Sep 24, 2026 Sep 14, 2026
4/A Filing Sep 24, 2026 Sep 14, 2026
4 Insider transaction Sep 17, 2026 Sep 14, 2026
4 Insider transaction Sep 17, 2026 Sep 14, 2026
4 Insider transaction Sep 17, 2026 Sep 14, 2026
4 Insider transaction Sep 17, 2026 Sep 14, 2026
4 Insider transaction Sep 17, 2026 Sep 14, 2026
4 Insider transaction Sep 17, 2026 Sep 14, 2026
4 Insider transaction Sep 17, 2026 Sep 14, 2026
424B3 Prospectus Sep 8, 2026 —
4 Insider transaction Aug 24, 2026 Aug 17, 2026
D Filing Aug 19, 2026 —
4 Insider transaction Aug 17, 2026 Aug 14, 2026
4 Insider transaction Aug 17, 2026 Aug 14, 2026
4 Insider transaction Aug 17, 2026 Aug 14, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Aug 17, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Aug 14, 2026 —
6-K Current report (foreign issuer) Aug 12, 2026 Aug 11, 2026
3 Initial insider ownership Jul 24, 2026 Jul 20, 2026
6-K Current report (foreign issuer) Jul 21, 2026 Jul 21, 2026
6-K Current report (foreign issuer) Jul 14, 2026 Jul 14, 2026
6-K Current report (foreign issuer) Jun 24, 2026 Jun 24, 2026
4 Insider transaction Jun 17, 2026 Jun 15, 2026
4 Insider transaction Jun 16, 2026 Jun 15, 2026
4 Insider transaction Jun 16, 2026 Jun 15, 2026
4 Insider transaction Jun 16, 2026 Jun 15, 2026
4 Insider transaction Jun 16, 2026 Jun 15, 2026
4 Insider transaction Jun 16, 2026 Jun 15, 2026
4 Insider transaction Jun 16, 2026 Jun 15, 2026
EFFECT Filing Jun 2, 2026 —
CORRESP Letter to the SEC May 28, 2026 —
4 Insider transaction May 19, 2026 May 17, 2026
F-3/A Filing May 15, 2026 —
6-K Current report (foreign issuer) Apr 27, 2026 Apr 27, 2026
20-F Annual report (foreign issuer) Apr 24, 2026 Dec 31, 2025
3/A Filing Apr 17, 2026 Mar 18, 2026
4 Insider transaction Apr 17, 2026 Mar 31, 2026
3/A Filing Apr 14, 2026 Mar 18, 2026
3/A Filing Apr 14, 2026 Mar 18, 2026
3/A Filing Apr 14, 2026 Mar 18, 2026
3/A Filing Apr 14, 2026 Mar 19, 2026
3/A Filing Apr 14, 2026 Mar 18, 2026
3/A Filing Apr 14, 2026 Mar 18, 2026
3/A Filing Apr 14, 2026 Mar 18, 2026
SCHEDULE 13D Ownership over 5% (active) Apr 8, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Apr 6, 2026 —
6-K Current report (foreign issuer) Apr 1, 2026 Apr 1, 2026
3 Initial insider ownership Mar 19, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
UPLOAD Letter from the SEC Mar 11, 2026 —
F-3 Shelf registration (foreign issuer) Mar 9, 2026 —
S-8 Employee stock plan registration Feb 2, 2026 —
6-K Current report (foreign issuer) Dec 22, 2025 Jun 30, 2025
6-K Current report (foreign issuer) Dec 12, 2025 Dec 11, 2025
6-K Current report (foreign issuer) Nov 19, 2025 Nov 19, 2025
6-K Current report (foreign issuer) Nov 18, 2025 Nov 17, 2025
6-K Current report (foreign issuer) Oct 21, 2025 Oct 21, 2025
6-K Current report (foreign issuer) Oct 16, 2025 Oct 15, 2025
6-K Current report (foreign issuer) Oct 14, 2025 Oct 14, 2025
6-K Current report (foreign issuer) Sep 25, 2025 Sep 25, 2025
SCHEDULE 13D Ownership over 5% (active) Sep 9, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Sep 5, 2025 —
6-K Current report (foreign issuer) Sep 5, 2025 Sep 5, 2025
6-K Current report (foreign issuer) Sep 3, 2025 Sep 3, 2025
6-K Current report (foreign issuer) Aug 28, 2025 Aug 28, 2025
6-K Current report (foreign issuer) Jul 25, 2025 Jul 25, 2025
20-F Annual report (foreign issuer) Apr 3, 2025 Dec 31, 2024
6-K Current report (foreign issuer) Apr 3, 2025 Apr 3, 2025
6-K Current report (foreign issuer) Mar 31, 2025 Mar 31, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 10, 2025 —
6-K Current report (foreign issuer) Dec 20, 2024 Dec 20, 2024
6-K Current report (foreign issuer) Dec 10, 2024 Dec 10, 2024
6-K Current report (foreign issuer) Nov 14, 2024 Nov 14, 2024
6-K Current report (foreign issuer) Nov 1, 2024 Nov 1, 2024
SC 13D/A Amended ownership over 5% (active) Aug 15, 2024 —
6-K Current report (foreign issuer) Aug 14, 2024 Jun 30, 2024
6-K Current report (foreign issuer) Aug 1, 2024 Aug 1, 2024
6-K Current report (foreign issuer) Jul 16, 2024 Jul 16, 2024
6-K Current report (foreign issuer) Jul 3, 2024 Jul 3, 2024
SC 13G/A Amended ownership over 5% (passive) May 30, 2024 —
EFFECT Filing May 29, 2024 —
424B3 Prospectus May 29, 2024 —
CORRESP Letter to the SEC May 28, 2024 —
6-K Current report (foreign issuer) May 24, 2024 May 24, 2024
424B5 Prospectus supplement May 24, 2024 —
UPLOAD Letter from the SEC May 24, 2024 —
SC 13D/A Amended ownership over 5% (active) May 22, 2024 —
F-3 Shelf registration (foreign issuer) May 20, 2024 —
SC 13G Ownership over 5% (passive) May 20, 2024 —
SC 13G Ownership over 5% (passive) May 20, 2024 —
6-K Current report (foreign issuer) May 8, 2024 May 8, 2024
6-K Current report (foreign issuer) Apr 25, 2024 Apr 25, 2024
EFFECT Filing Apr 24, 2024 —
EFFECT Filing Apr 24, 2024 —
424B3 Prospectus Apr 24, 2024 —
424B3 Prospectus Apr 24, 2024 —
CORRESP Letter to the SEC Apr 22, 2024 —
CORRESP Letter to the SEC Apr 22, 2024 —
CORRESP Letter to the SEC Apr 19, 2024 —
CORRESP Letter to the SEC Apr 19, 2024 —
F-3/A Filing Apr 19, 2024 —
F-3/A Filing Apr 19, 2024 —
UPLOAD Letter from the SEC Apr 16, 2024 —
UPLOAD Letter from the SEC Apr 16, 2024 —
CORRESP Letter to the SEC Apr 12, 2024 —
CORRESP Letter to the SEC Apr 12, 2024 —
UPLOAD Letter from the SEC Apr 12, 2024 —
UPLOAD Letter from the SEC Apr 12, 2024 —
F-3 Shelf registration (foreign issuer) Apr 1, 2024 —
F-3 Shelf registration (foreign issuer) Apr 1, 2024 —
20-F Annual report (foreign issuer) Mar 28, 2024 Dec 31, 2023
6-K Current report (foreign issuer) Mar 28, 2024 Mar 28, 2024
424B3 Prospectus Mar 4, 2024 —
6-K Current report (foreign issuer) Mar 4, 2024 Mar 4, 2024
SC 13G Ownership over 5% (passive) Feb 27, 2024 —
6-K Current report (foreign issuer) Jan 19, 2024 Jan 19, 2024
6-K Current report (foreign issuer) Jan 8, 2024 Jan 8, 2024
SC 13D/A Amended ownership over 5% (active) Nov 29, 2023 —
144 Notice of proposed sale Nov 27, 2023 —
SC 13D/A Amended ownership over 5% (active) Nov 20, 2023 —
424B3 Prospectus Nov 16, 2023 —
144 Notice of proposed sale Nov 16, 2023 —
SC 13D/A Amended ownership over 5% (active) Nov 1, 2023 —
144 Notice of proposed sale Oct 30, 2023 —
424B3 Prospectus Oct 26, 2023 —
424B3 Prospectus Oct 25, 2023 —
SC 13D Ownership over 5% (active) Oct 10, 2023 —
144 Notice of proposed sale Oct 5, 2023 —
SC 13D/A Amended ownership over 5% (active) Oct 2, 2023 —
EFFECT Filing Sep 29, 2023 —
424B3 Prospectus Sep 29, 2023 —
POS AM Filing Sep 28, 2023 —
424B3 Prospectus Sep 28, 2023 —
6-K Current report (foreign issuer) Sep 28, 2023 Jun 30, 2023
424B3 Prospectus Jul 25, 2023 —
EFFECT Filing Jul 24, 2023 —
6-K Current report (foreign issuer) Jul 20, 2023 Jul 20, 2023
CORRESP Letter to the SEC Jul 20, 2023 —
CORRESP Letter to the SEC Jul 7, 2023 —
F-1/A Filing Jul 7, 2023 —
UPLOAD Letter from the SEC Jun 23, 2023 —
S-8 Employee stock plan registration Jun 9, 2023 —
F-1 Registration statement (foreign issuer) Jun 9, 2023 —
20-F Annual report (foreign issuer) Apr 28, 2023 Dec 31, 2022
SC 13D Ownership over 5% (active) Apr 12, 2023 —
20-F Annual report (foreign issuer) Mar 31, 2023 Mar 29, 2023
6-K Current report (foreign issuer) Mar 30, 2023 Mar 30, 2023
CERT Filing Mar 29, 2023 —
8-A12B Filing Mar 28, 2023 —
SEC STAFF LETTER Filing Mar 6, 2023 —
EFFECT Filing Feb 28, 2023 —
424B3 Prospectus Feb 28, 2023 —
CORRESP Letter to the SEC Feb 24, 2023 —
CORRESP Letter to the SEC Feb 21, 2023 —
F-4/A Filing Feb 21, 2023 —
UPLOAD Letter from the SEC Feb 17, 2023 —
F-4/A Filing Feb 10, 2023 —
425 Filing Feb 10, 2023 —
F-4/A Filing Dec 23, 2022 —
CORRESP Letter to the SEC Dec 22, 2022 —
UPLOAD Letter from the SEC Dec 19, 2022 —
F-4/A Filing Dec 15, 2022 —
CORRESP Letter to the SEC Dec 14, 2022 —
UPLOAD Letter from the SEC Dec 5, 2022 —
SEC STAFF LETTER Filing Dec 2, 2022 —
CORRESP Letter to the SEC Nov 22, 2022 —
F-4 Filing Nov 22, 2022 —
425 Filing Nov 15, 2022 —
UPLOAD Letter from the SEC Oct 26, 2022 —
425 Filing Oct 14, 2022 —
425 Filing Oct 7, 2022 —
DRS Filing Sep 29, 2022 —
425 Filing Sep 15, 2022 —
425 Filing Sep 14, 2022 —
425 Filing Sep 14, 2022 —
425 Filing Sep 14, 2022 —

Showing 183 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
APLM (Nasdaq), APLMW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Cayman Islands
Headquarters
Covina, CA
SEC filer status
Non-accelerated filer, Emerging growth company
SEC CIK
1944885

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.